Search | Webyourself Social Media Platform

added article Health

2024-08-21 04:02:36 -

Repotrectinib Market Latest Technological Developments Report by 2034

Repotrectinib is a next-generation tyrosine kinase inhibitor (TKI) developed to target specific genetic mutations, particularly in cases of non-small cell lung cancer (NSCLC) and other solid tumors. It has gained attention due to its efficacy in patients with ROS1-positive NSCLC, a subset of lung cancer characterized by a mutation in the ROS1 gene. Repotrectinib's unique ability to cross the...

0 Comments 0 Shares 355 Views 0 Reviews